ASH 2019: Dr. Jennifer Brown on ATM gene variants in chronic lymphocytic leukemia (CLL) ASH 2019: Dr. Jennifer Brown on ATM gene variants in chronic lymphocytic leukemia (CLL)... Details
ASH 2019: Dr. Paul Barr on Ibrutinib as an Early Line Treatment for Chronic Lymphocytic Leukemia (CLL) During ASH 2019, our own Dr. Brian Koffman interviewed Dr. Paul Barr, Associate Professor of Medicine at the Wilmot Cancer... Details
ASH 2019: Dr. Byrd on what we still don’t know about chronic lymphocytic leukemia (CLL) Please enjoy this short interview of Dr. John Byrd by Patty Koffman, the CLL Society’s Communication Director from ASH 2019.... Details
iwCLL 2019: Dr. David Maloney on targeted agents, transplants, and CAR-T therapy for treating chronic lymphocytic leukemia (CLL) iwCLL 2019: Dr. David Maloney on targeted agents, transplants, and CAR-T therapy for treating chronic lymphocytic leukemia (CLL)... Details
ASH 2019: Dr. Adrian Wiestner on clonal evolution in chronic lymphocytic leukemia (CLL) ASH 2019: Dr. Adrian Wiestner on clonal evolution in chronic lymphocytic leukemia (CLL) ... Details
ASH 2019: Dr. Stephens Discusses a Clinical Trial of Ibrutinib + First in Class SINE Compound for CLL In this ASH 2019 interview with Dr. Brian Koffman, Dr. Debbie Stephens discusses her clinical trial combining Selinexor with ibrutinib... Details
ASH 2019: Dr. Siddiqi Discusses a Clinical Trial of Lisocel®, a CAR-T Therapy for CLL ASH 2019: Dr. Siddiqi Discusses a Clinical Trial of Lisocel®, a CAR-T Therapy for CLL ... Details
ASH 2019: Dr. Sameer Parikh on Monoclonal B-cell Lymphocytosis, a Precursor to Chronic Lymphocytic Leukemia (CLL) ASH 2019: Dr. Sameer Parikh on Monoclonal B-cell Lymphocytosis, a Precursor to Chronic Lymphocytic Leukemia (CLL) ... Details
iwCLL 2019: Dr. Andy Rawstron on minimal residual disease (MRD) testing for chronic lymphocytic leukemia (CLL) In this 2019 iwCLL interview with Dr. Andy Rawstrom, we learn that he is a clinical scientist who helps with... Details
ASH 2019: Dr. Brian Koffman on our Expert Access™ Program for patients with chronic lymphocytic leukemia (CLL) ASH 2019: Dr. Brian Koffman on our Expert Access™ Program for patients with chronic lymphocytic leukemia (CLL) ... Details
